Neuronal membrane phospholipid biosynthesis

Neuronal membrane phospholipid biosynthesis is the metabolic process responsible for the production of phospholipids, such as phosphatidylcholine, which are the primary structural components of neuronal membranes and synapses (Wurtman, 2014). This process occurs largely through the Kennedy pathway, utilizing circulating precursors including choline, uridine, and polyunsaturated fatty acids like docosahexaenoic acid (DHA) (Kennedy & Weiss, 1956). In neurodegenerative diseases, particularly Alzheimer's disease, there is a significant loss of synapses and a depletion of membrane phospholipids, contributing to cognitive decline (Scheltens et al., 2012). Therapeutic interventions, often in the form of medical foods or multinutrient combinations like Fortasyn Connect, aim to increase the availability of these rate-limiting precursors to stimulate the synthesis of new membranes and support synaptogenesis (Cansev, 2006). By enhancing the structural integrity of neurons, this approach seeks to preserve or restore connectivity and improve clinical outcomes in patients with early-stage dementia. The pathway involves several key enzymes, including choline kinase and CTP:phosphocholine cytidylyltransferase, which are regulated by the availability of their respective substrates (Wurtman et al., 2009). Research indicates that co-administration of these precursors has a synergistic effect on phospholipid levels and synaptic protein expression compared to individual components (Wurtman, 2014). While not a single protein target, this biosynthetic process represents a systems-biology approach to treating synaptic loss in the aging brain.

Other names

Kennedy pathwayPhospholipid synthesisSynaptogenesis pathway

Substrate enrichment of the Kennedy pathway to increase the synthesis of membrane phospholipids, thereby supporting synaptic formation and function.